The Efficacy of a Single Dose of Intranasal Oxytocin in the Prevention of Post Traumatic Stress Disorder (PTSD)
ClinicalTrials.gov · NCT01039766 · Registry updated: 2010-02-09
- Condition / research focus
- Stress Disorders, Post-Traumatic
- Sponsor
- Sheba Medical Center
- Countries with listed sites
- Israel
- Registry dates and results
- Start: 2010-02. Completion: 2011-06 (may be estimated). No results posted in this registry response.
Products and interventions (2)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
- Oxytocin (drug) — also listed as: syntocinon nasal spray
- placebo - saline nasal spray (drug) — also listed as: saline nasal spray prepared by the hospital's pharmacy
Where the study takes place — 1 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
- Sheba Medical Center
Ramat Gan, Israel
Site recruitment: Recruiting